Tomozumi Imamichi

9.8k citations
89 papers · 6.1k indexed · 1 hit paper · h-index 28
  • Virology top 0.5%
    • HIV Research and Treatment 34
  • Immunology top 1%
    • Immune Cell Function and Interaction 22
    • interferon and immune responses 14
    • Immune Response and Inflammation 7
    • HIV/AIDS drug development and treatment 20
    • HIV/AIDS Research and Interventions 9
    • Cytomegalovirus and herpesvirus research 7
    • Herpesvirus Infections and Treatments 6

Tomozumi Imamichi

89 papers receiving 6.0k citations

Hit Papers

DAVID: a web server for functional enrichment analysis an...3.2k202220262023202410002.0k3.0k

Peers

Tomozumi Imamichi
Comparison fields: 5 of 144
  • Virology 1.0k
  • Immunology 1.5k
  • Cancer Research 792
  • Infectious Diseases 968
  • Molecular Biology 2.8k
Replace W. Gregory Alvord with:
W. Gregory Alvord United States
Ugo Moens Norway
Zhiqiang Zhang China
Yu Zhou China
Takashi Okamoto Japan
Licia Tomei Italy
Yi Liu China
Steven R. Head United States
Jin Wang United States
Tomozumi Imamichi relative to W. Gregory Alvord United States W. Gregory Alvord's profile →
Citations per field
00.5×8.9×
W. Gregory Alvord · 1×
Citations per year

Countries citing papers authored by Tomozumi Imamichi

Since Specialization
Citations

This map shows the geographic impact of Tomozumi Imamichi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomozumi Imamichi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomozumi Imamichi more than expected).

Fields of papers citing papers by Tomozumi Imamichi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomozumi Imamichi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomozumi Imamichi. The network helps show where Tomozumi Imamichi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tomozumi Imamichi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tomozumi Imamichi Line = papers co-authored together Tomozumi Imamichi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20226
3 202123
4 201914
5 20193
6 201829
7 201721
8 201630
9 201636
10 201541
11 201342
12 20111
13 201112
14 201061
15 200887
16 200468
17 200313
18 1994102
19 199320
20 19905

About Tomozumi Imamichi

Tomozumi Imamichi is a scholar working on Virology, Immunology and Biological Psychiatry, having authored 89 papers that have together received 6.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (34 papers), Immune Cell Function and Interaction (22 papers), HIV/AIDS drug development and treatment (20 papers), interferon and immune responses (14 papers), HIV/AIDS Research and Interventions (9 papers), Immune Response and Inflammation (7 papers), Cytomegalovirus and herpesvirus research (7 papers) and Herpesvirus Infections and Treatments (6 papers). The work is most often cited by research in Virology (1.0k citations), Immunology (1.5k citations) and Cancer Research (792 citations). Tomozumi Imamichi has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include H. Clifford Lane, Brad T. Sherman, Michael Baseler, Xiaoli Jiao, Weizhong Chang, Ming Hao, Ju Qiu, Jun Yang, Hiromi Imamichi and Richard A. Lempicki. Their work appears in journals such as AIDS, Journal of Virology, Viruses, Molecular Immunology and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026